MS Drug Takes a Feisty Approach Aimed at Younger Patients

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

MS Drug Takes a Feisty Approach Aimed at Younger Patients

Postby MSUK » Wed Apr 03, 2013 11:52 pm

An MS Drug Takes a Feisty Approach Aimed at Younger Patients

The Swiss drug maker Novartis is taking a sassy new tack to win converts to its oral multiple sclerosis treatment, Gilenya. Its “Hey MS, Take This!” campaign shows patients sticking out their tongues with Gilenya capsules on them to show their willingness to fight back against the neurological condition..... Read More - http://www.ms-uk.org/index.cfm/MSnews
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2225
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Return to Gilenya

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service